2019 annual financial data
Candel Therapeutics 2019 Operating margin
Direct answer
Operating margin was -7,229.6%.
Operating income was -9,037,000 USD and net income was -8,240,000 USD.
Operating cash flow was Not available.
Get free Candel Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 125,000 USD
- Operating income
- -9,037,000 USD
- Net income
- -8,240,000 USD
- Operating cash flow
- Not available